Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine... see more

Recent & Breaking News (TSXV:IBO)

Universal Ibogaine Advises of Application for Management Cease Trade Order

TheNewsWire 2 days ago

Universal Ibogaine to Issue Common Shares Pursuant to Debt Settlement

TheNewsWire June 17, 2024

Universal Ibogaine announces closing of private placement financing

TheNewsWire June 7, 2024

Universal Ibogaine provides update on planned Clinical Trial Application process

TheNewsWire April 29, 2024

Universal Ibogaine Announces Private Placement Financing and the Results of the Annual Meeting of Shareholders

TheNewsWire April 22, 2024

Universal Ibogaine announces new private placement financing

TheNewsWire April 12, 2024

Universal Ibogaine announces closing of private placement financing

TheNewsWire April 10, 2024

Universal Ibogaine advises of management change

TheNewsWire April 8, 2024

Universal Ibogaine Announces Additional Private Placement Financing

TheNewsWire February 22, 2024

Universal Ibogaine Advises of Closing of Private Placement Financing

TheNewsWire February 7, 2024

Universal Ibogaine provides final Bi-weekly Default Status Report on year-end and Q1 filings

TheNewsWire February 2, 2024

Universal Ibogaine provides Bi-weekly Default Status Report and update on status of Private Placement

TheNewsWire January 19, 2024

Universal Ibogaine provides Bi-weekly Default Status Report

TheNewsWire January 5, 2024

Universal Ibogaine Advises of Appointment of New Auditors and Private Placement

TheNewsWire December 21, 2023

Universal Ibogaine Announces Granting of Management Cease Trade Order

TheNewsWire December 11, 2023

Universal Ibogaine provides update on prior application for Management Cease Trade Order

TheNewsWire December 1, 2023

Universal Ibogaine Advises of Application for Management Cease Trade Order

TheNewsWire November 20, 2023

Universal Ibogaine Advises of Board Member Changes

TheNewsWire October 12, 2023

Universal Ibogaine Engages Mike "Zappy" Zapolin as a Strategic Advisor

TheNewsWire October 4, 2023

Universal Ibogaine Provides Corporate Update on Belize Property and Notice of Resignation of Auditors

TheNewsWire September 6, 2023